lunes, 16 de junio de 2025
Nearly half of breast cancer patients continue hormone therapy beyond five years +++++
Nearly half of breast cancer patients continue hormone therapy beyond five years
Nearly half of breast cancer patients continue hormone therapy beyond five yearsAs recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds light on whether patients are opting for it.
https://www.news-medical.net/news/20250609/Nearly-half-of-breast-cancer-patients-continue-hormone-therapy-beyond-five-years.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=breast_cancer_newsletter_11_june_2025
Early camizestrant therapy keeps advanced breast cancer in check
Early camizestrant therapy keeps advanced breast cancer in checkSwitching to camizestrant, a next-generation oral SERD, significantly prolongs progression-free survival and maintains quality of life in patients with ESR1-mutated, hormone receptor-positive advanced breast cancer. The proactive, biomarker-guided approach allows earlier intervention and may redefine standard care.
https://www.news-medical.net/news/20250603/Early-camizestrant-therapy-keeps-advanced-breast-cancer-in-check.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=breast_cancer_newsletter_11_june_2025
THP regimen achieves high response rates in HER2 positive breast cancer patients
THP regimen achieves high response rates in HER2 positive breast cancer patientsPatients with Stage II and III (early-stage) HER2+ breast cancer usually undergo pre-operative therapy with multi-agent chemotherapy in combination with anti-HER2 antibodies, followed by surgery.
https://www.news-medical.net/news/20250602/THP-regimen-achieves-high-response-rates-in-HER2-positive-breast-cancer-patients.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=breast_cancer_newsletter_11_june_2025
Culturally tailored program supports emotional health of Latina breast cancer survivors
Culturally tailored program supports emotional health of Latina breast cancer survivorsA recent randomized controlled trial assessed the benefits of a group-based intervention that fosters communication and coping skills in a culturally tailored way for Latina breast cancer survivors and their caregivers.
https://www.news-medical.net/news/20250604/Culturally-tailored-program-supports-emotional-health-of-Latina-breast-cancer-survivors.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=breast_cancer_newsletter_11_june_2025
Myeloid cells shape tumor microenvironments and influence cancer progression
Myeloid cells shape tumor microenvironments and influence cancer progressionRecent advances in cancer research have underscored the critical role of myeloid cells in shaping tumor microenvironments (TME), influencing tumor progression, immune evasion, and therapeutic resistance.
https://www.news-medical.net/news/20250603/Myeloid-cells-shape-tumor-microenvironments-and-influence-cancer-progression.aspx?utm_source=news_medical_newsletter&utm_medium=email&utm_campaign=breast_cancer_newsletter_11_june_2025
Suscribirse a:
Enviar comentarios (Atom)


No hay comentarios:
Publicar un comentario